Hayes L J, Pecharatana S, Bailey R L, Hampton T J, Pickett M A, Mabey D C, Watt P J, Ward M E
Southampton University Medical School, United Kingdom.
J Infect Dis. 1995 Jul;172(1):268-72. doi: 10.1093/infdis/172.1.268.
Variants of Chlamydia trachomatis in two Gambian villages with hyperendemic trachoma were analyzed by omp1-based polymerase chain reaction and sequencing from conjunctival swabs. Samples collected over a 22-month period included a complete cross-sectional study of each village. Overall, 4 genovar A and 4 B variants were characterized by point mutations in the omp1 gene, resulting in changes in the inferred amino acid sequence. Two genovar A and 2 B variants accounted for 87% of the total ocular chlamydial infection in both villages. Although some flux in the prevalence of individual variants was observed overtime, their overall distribution remained remarkably stable. There was no evidence of major antigenic shift arising from recombination events at the omp1 locus as described for genital tract infection. These results indicate that omp1 variation in these two trachoma-hyperendemic communities is limited and unlikely to hamper development of trachoma vaccines based on the major outer membrane protein.
通过基于omp1的聚合酶链反应和结膜拭子测序,对冈比亚两个沙眼高度流行村庄的沙眼衣原体变体进行了分析。在22个月期间收集的样本包括对每个村庄的完整横断面研究。总体而言,4种基因变种A和4种B变体通过omp1基因中的点突变得以表征,导致推断的氨基酸序列发生变化。两种基因变种A和2种B变体占两个村庄眼部衣原体感染总数的87%。尽管随着时间的推移观察到个别变体的流行率有一些波动,但其总体分布仍保持显著稳定。没有证据表明如生殖道感染中所描述的那样,在omp1位点发生重组事件会导致主要抗原转变。这些结果表明,这两个沙眼高度流行社区中的omp1变异有限,不太可能妨碍基于主要外膜蛋白的沙眼疫苗的开发。